Abstract:Background: Currently, no satisfactory biomarkers are available to screen for lung cancer. Surface-Enhanced Laser Desorption/ionization Time-of- Flight Mass Spectrometry ProteinChip system (SELDI-TOF-MS) is one of the currently used techniques to identify biomarkers for cancers. The aim of this study is to explore the application of serum SELDI proteomic patterns to distinguish lung cancer patients from healthy individuals.Methods: A total of 208 serum samples, including 158 lung cancer patients and 50 healthy individuals, were randomly divided into a training set (including 11 sera from patients with stages I/II lung cancer, 63 from patients with stages III/IV lung cancer and 20 from healthy controls) and a blinded test set (including 43 sera from patients with stages I/II lung cancer, 41 from patients with stages III/IV lung cancer and 30 from healthy controls). All samples were analyzed by SELDI technology. The spectra were generated on weak cation exchange (WCX2) chips, and protein peaks clustering and classification analyses were made using Ciphergen Biomarker Wizard and Biomarker Pattern software, respectively. We additionally determined Cyfra21-1 and NSE in the 208 serum samples included in this study using an electrochemiluminescent immunoassay.Results: Five protein peaks at 11493, 6429, 8245, 5335 and 2538 Da were automatically chosen as a biomarker pattern in the training set. When the SELDI marker pattern was tested with the blinded test set, it yielded a sensitivity of 86.9%, a specificity of 80.0% and a positive predictive value of 92.4%. The sensitivities provided by Cyfra21-1 and NSE used individually or in combination were significantly lower than that of the SELDI marker pattern (P < 0.005 or 0.05, respectively). Based on the results of the test set, we found that the SELDI marker pattern showed a sensitivity of 91.4% in the detection of non-small cell lung cancers (NSCLC), which was significantly higher than that in the detection of small cell lung cancers (P < 0.05); The pattern also had a sensitivity of 79.1% in the detection of lung cancers in stages I/II.Conclusion: These results suggest that serum SELDI protein profiling can distinguish lung cancer patients, especially NSCLC patients, from normal subjects with relatively high sensitivity and specificity, and the SELDI- TOF- MS is a potential tool for the screening of lung cancer.

Diagnosis of pancreatic adenocarcinoma using protein chip technology.

Evaluation of the Effectiveness of a Chemoprevention Model of Pancreatic Adenocarcinoma Using Protein Chip Technology.

Screening for Protein Markers from Serum of Patients with Pancreatic Carcinoma by Protein Finger Printing Technique

[Use of Laser Capture Microdissection and Surface-Enhanced Laser Desorption Ionization Time-of-flight Mass Spectrometry to Screen Differential Proteins in Lung Adenocarcinoma and Lung Squamous Carcinoma].

[Establishment of serum protein pattern model for screening pancreatic cancers by SELDI-TOF-MS technique]

Construction of protein profiling models for diagnosis of pancreatic carcinoma

Identification of serum biomarkers for pancreatic adenocarcinoma by proteomic analysis

New Serum Biomarkers For Early Diagnosis Of Prostate Cancer Using Seldi Protein Chip Technology

Prediction Of Pancreatic Cancer By Serum Biomarkers Using Surface-Enhanced Laser Desorption/Ionization-Based Decision Tree Classifi Cation

Application of Seldi-Tof-Ms Coupled with an Artificial Neural Network Model to the Diagnosis of Pancreatic Cancer

A Serum Proteomic Pattern for the Detection of Colorectal Adenocarcinoma Using Surface Enhanced Laser Desorption and Ionization Mass Spectrometry

Application of Surface-Enhanced Laser Desorption/ionization Time-of-flight-based Serum Proteomic Array Technique for the Early Diagnosis of Prostate Cancer

[Application of Serum Protein Profiling in Diagnosis, Prognosis and Evaluation of Curative Effect of Pancreatic Adenocarcinoma].

[A Predictive Model for Pancreatic Cancer Using Serum Protein Footprint Map].

[Application of Serum Protein Pattern Model in Diagnosis of Colorectal Cancer].

A protein chip system for parallel analysis of multi-tumor markers and its application in cancer detection.

Proteomic Approaches to Biomarker Discovery in Lung Cancers by SELDI Technology

Protein Fingerprint of Colorectal Cancer, Adenomatous Polyps, and Normal Mucosa Using ProteinChip Analysis on Laser Capture Microdissected Cells.

Application of Serum Surface-Enhanced Laser Desorption/ionization Proteomic Patterns in Distinguishing Lung Cancer Patients from Healthy People.

Screening Serum Biomarkers for Pancreatic Cancer by Serum Proteomics Techniques

Application of Serum Seldi Proteomic Patterns in Diagnosis of Lung Cancer